- Q: How serious a problem is influenza in the United States?
- Q: Please summarize what’s new in CDC’s 2025–26 season influenza vaccine recommendations.
- Q: Are any of the available influenza vaccines recommended over others?
- Q: When does CDC recommend starting influenza vaccination?
- Q: For which vaccines is an egg allergy a contraindication?
- Q: How long after someone is vaccinated with FluMist (LAIV) must they stay away from a severely immunosuppressed person (a person who is hospitalized in protective [reverse] isolation)?
- Q: Can a clinic vaccinate children younger than age 3 years with influenza vaccine taken from a multidose vial (MDV) of influenza vaccine? The MDVs contain thimerosal as a preservative.
- Q: Does ACIP recommend one influenza product over another during pregnancy?
- Q: What is the ACIP recommendation for RSV vaccination of older adults?
- Q: What are the three RSV vaccines and how are they different?
- Q: Is there information on how well RSV vaccines have worked in the first season they were used?
- Q: How serious is RSV in children?
- Q: What is the recommendation for use of RSV vaccine during pregnancy?
- Q: What is clesrovimab preventive antibody and how well does it work?
- Q: When is the optimal timing for infants and toddlers to receive an RSV preventive antibody product?
- Q: When should palivizumab (Synagis) be used now that nirsevimab and clesrovimab are recommended?
- Q: Is there a strict limit to the volume of vaccine and/or monoclonal antibody that can be administered in a single limb (deltoid or thigh) at one immunization visit?
- Q: What are the side effects of RSV preventive antibody products?


